跳至主要内容
临床试验/TCTR20200211001
TCTR20200211001尚未招募4 期

Role of Prucalopride treatment of chronic constipation in Parkinson disease

Faculty of Medicine, Siriraj Hospital0 个研究点目标入组 80 人开始时间: 2020年2月11日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • Inclusion Criteria
  • -patients who age of >/=18 years old
  • -Has been diagnosed as Parkinson disease according to UKPDS Brain bank criteria who are in stable disease (no need for medication adjustment at least 4 weeks before enrollment.
  • -Met criteria of chronic constipation according to ROME IV criteria (ROME IV diagnosis criteria for constipation)

排除标准

  • Exclusion Criteria
  • - Had alternative cause of chronic constipation eg.
  • oHistory of abdominal surgery except anorectal surgery, appendectomy and cholecystectomy.
  • oRecieve drugs which effect GI motility eg. opioids, anticholinergic agents
  • oHave endrocrinologic disease or metabolic derangement which caused constipation eg.hypothyroidism, hypercalcemia
  • omegacolon/megarectum, pseudo-colonic obstruction
  • -Has been diagnosed as colonic cancer before the enrolment all participants with age 50 year should be underwent colonic cancer screening
  • -Allergic to prucalopride or medication component.
  • -Currently treated with prucalopride before the enrollment.
  • -Severe dementia or unable to fill the questionnaires.
  • -Pregnant or lactating women.

研究者

发起方
Faculty of Medicine, Siriraj Hospital

相似试验